A growing number of government efforts and rising incidence of issues with vision, cognition, hearing, and mobility in the elderly are some of the main factors influencing market revenue growth.
Market size will reach USD 8,374.2 million in 2021; market growth will occur at a CAGR of 10.6%, and the use of telemedicine to treat cognitive impairments will increase.
According to the most recent analysis by Emergent Research, the size of the U.S. assistive technology (AT) market for people with disabilities was USD 8,374.2 million in 2021 and is projected to grow at a revenue CAGR of 10.6% over the forecast period. Major drivers influencing market revenue growth between 2022 and 2030 include the increased incidence of visual, cognitive, auditory, and mobility-related issues in geriatric persons as well as the rising number of government programs to improve the quality of life for people with disabilities.
The prevalence of assistive technologies (AT), which include tools, modalities, and platforms specifically created to help people with mobility, cognitive, behavioral, or visual impairments function, has grown dramatically over time. According to statistics from the Centers for Disease Control and Prevention (CDC), 1 in every 4 Americans, or over 61 million people, has a disability that significantly limits their ability to carry out daily tasks. The CDC has also made further observations and linked a rise in the prevalence of disabilities to a fall in income. Additionally, an increase in research projects looking for low-cost technologies to help patients with disabilities is anticipated to boost demand for assistive technology modalities over the next few years and significantly fuel market revenue growth.
However, a significant factor limiting market revenue growth over the forecast period is the high cost of machinery and procedures.
Some Significant Report Highlights:
In terms of revenue, the assistive technology for disabilities market in the United States in 2021 was dominated by the mobility impairments category. The continued usage of wheelchairs in hospitals, nursing homes, and other institutions as well as the quick development of electronic joystick-controlled wheelchairs due to technological improvements are the main drivers of this market’s revenue growth. Approximately one in seven people, or over 34 million people, have mobility-related illnesses, with every second patient being over 65 years old, according to the Centers for Disease Control and Prevention (CDC).
Between 2022 and 2030, the blindness and low vision market are anticipated to have consistent revenue growth. A few of the drivers driving this segment’s revenue growth are the rising prevalence of vision-related issues in the senior population pool, the expansion of government initiatives, rising public awareness of assistive technology for the blind, and technological advancements. For example, Eyedaptic, Inc., a developer of natural vision software, declared in June 2021 that EYE3, an updated and improved version of their eyewear solution, is now ready to assist persons with retinal-related vision disorders including Age-related Macular Degeneration (AMD).
During the projection period, the special education segment is anticipated to have high CAGR growth. Some of the main factors influencing this segment’s revenue growth are public and private initiatives to support the development of national policies and education programs using assistive technologies and devices, as well as the development of human resources and education for people with disabilities.
Major companies in the market report include AssistiveWare, Attainment Company, Control Bionics, Daedalus Technologies, Double Robotics, Don Johnston Inc., School Health, Freedom Scientific, Hamilton CapTel, and HumanWare.
Control Bionics established cooperation with Double R&D on April 11, 2022, to introduce NeuroNode technology in Japan. To broaden its regional reach and connect with additional patients in this area, the former company and the latter company have inked a contract. Patients with illnesses like ALS, cerebral palsy, intellectual incapacity, traumatic brain injuries, and strokes can benefit most from the device. According to this arrangement, Double R&D will be Control Bionics’ sole distributor in Japan, and orders will be fulfilled according to product costs.
The assistive technology market in the United States has been divided into segments by device type, indication, distribution method, end-use, and geography by Emergen Research:
Device Type Outlook (Revenue, USD Million, 2019 – 2030)
- Mobility Impairments
- Transfer Devices
- Visual Impairments
- Screen Readers
- Braille and Braille Embossers
- Refreshable Braille Display
- Wearable Technology
- Hearing Impairment Devices
- Hearing Aids
- Assistive Listening Devices
- Amplified Telephone Equipment
- Cognitive Impairments
- Memory Aids
- Educational Software
- Speech Impairments
- Other Device Types
- Mobility Impairments
Indication Outlook (Revenue, USD Million, 2019 – 2030)
- Autism Spectrum Disorders
- Blindness and Low Vision
- Deafness and Hard of Hearing
- Computer Access Problems
- Communication Disorders
- Mobility Impairment
- Cognitive Disabilities
Distribution Channel Outlook (Revenue, USD Million, 2019 – 2030)
- Company Website
- Third-party Website
End-User Outlook (Revenue, USD Million, 2019 – 2030)
- Special Education
- Veterans Administration
- Home and Community-based Services
- Federal/State Government (Disability and Older Adults)
- Rehabilitation and Training Programs
To get leading market solutions, Visit the Link